Abstract
Breast cancer, the most common neoplasm in women worldwide, is characterized by heterogeneous genetic alterations in breast cells. Early screening of the disease is crucial for better patient prognosis, playing a key role in combating mortality rates associated with the disease. Interval tumors, which arise between regular screenings, tend to have rapid progression and worse prognosis, of…